Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [8]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12160-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12160-1-AP, RRID:AB_10598009
- Product name
- PAR2 antibody
- Antibody type
- Polyclonal
- Description
- PAR2 antibody (Cat. #12160-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Linagliptin's impact on lymphatic barrier and lymphangiogenesis in oral cancer with high glucose.
Protease-Activated Receptor-2 and Phospholipid Metabolism Analysis in Hyperuricemia-Induced Renal Injury.
Long non-coding RNA AC245100.4 activates the PI3K/AKT pathway to promote PCa cell proliferation by elevating PAR2.
Choroid plexus mast cells drive tumor-associated hydrocephalus.
Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway.
Modulation of Intestinal Epithelial Permeability via Protease-Activated Receptor-2-Induced Autophagy.
Protease-activated receptor-2 promotes kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway.
Toward drugs for protease-activated receptor 2 (PAR2).
Wang H, She X, Xu Q, Zhou X, Tang Q, Wei H, Huang T, Liang F
Oral diseases 2024 Oct;30(7):4195-4208
Oral diseases 2024 Oct;30(7):4195-4208
Protease-Activated Receptor-2 and Phospholipid Metabolism Analysis in Hyperuricemia-Induced Renal Injury.
Sui X, Xie T, Xu Y, Zhang A, Zhang Y, Gu F, Li L, Xu Z, Chen J
Mediators of inflammation 2023;2023:5007488
Mediators of inflammation 2023;2023:5007488
Long non-coding RNA AC245100.4 activates the PI3K/AKT pathway to promote PCa cell proliferation by elevating PAR2.
Zhang K, Liu C, Hu C, Lin P, Qi Q, Jia H, Tang J, Yu X
Heliyon 2023 Jun;9(6):e16870
Heliyon 2023 Jun;9(6):e16870
Choroid plexus mast cells drive tumor-associated hydrocephalus.
Li Y, Di C, Song S, Zhang Y, Lu Y, Liao J, Lei B, Zhong J, Guo K, Zhang N, Su S
Cell 2023 Dec 21;186(26):5719-5738.e28
Cell 2023 Dec 21;186(26):5719-5738.e28
Long non-coding RNA AC245100.4 contributes to prostate cancer migration via regulating PAR2 and activating p38-MAPK pathway.
Liu C, Jiang S, Xie H, Jia H, Li R, Zhang K, Wang N, Lin P, Yu X
Medical oncology (Northwood, London, England) 2022 May 16;39(5):94
Medical oncology (Northwood, London, England) 2022 May 16;39(5):94
Modulation of Intestinal Epithelial Permeability via Protease-Activated Receptor-2-Induced Autophagy.
Kim Y, Lee Y, Heo G, Jeong S, Park S, Yoo JW, Jung Y, Im E
Cells 2022 Mar 3;11(5)
Cells 2022 Mar 3;11(5)
Protease-activated receptor-2 promotes kidney tubular epithelial inflammation by inhibiting autophagy via the PI3K/Akt/mTOR signalling pathway.
Du C, Zhang T, Xiao X, Shi Y, Duan H, Ren Y
The Biochemical journal 2017 Aug 2;474(16):2733-2747
The Biochemical journal 2017 Aug 2;474(16):2733-2747
Toward drugs for protease-activated receptor 2 (PAR2).
Yau MK, Liu L, Fairlie DP
Journal of medicinal chemistry 2013 Oct 10;56(19):7477-97
Journal of medicinal chemistry 2013 Oct 10;56(19):7477-97
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The PAR2 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human PAR2. This antibody recognizes human,mouse,rat antigen. The PAR2 antibody has been validated for the following applications: ELISA, WB analysis.
